Synergy of Minds and Talents

Scientists, health professionals, and community advocates are working together to transform health.

COLS Creators

We started the Colorado Longitudinal Study because we know that we don’t have all the information we need about health and sickness. It’s not because we lack imagination but because we don’t have the right data. This data is essential for scientists to use modern tools, like quantum computing, to learn about what makes us healthy and what makes us sick.

COLS is being built to gather enormous sets of important data that can help solve current limitations with research. Brilliant researchers, doctors, community health supporters, and philanthropists are working together to make COLS become a reality. They are all giving their time because they are passionate and believe we can make health and healthcare better.

Our Cornerstones

While the people who are building COLS come from different disciplines, different organizations, and different points of view, we are all united by a common set of values:

  • We are passionate about shaping the future of health and know this is only possible by pushing the boundaries of what we believe is possible. We aren’t satisfied with what we already know.
  • We exist to transform the collective understanding of health and won’t stop until health and healthcare are revolutionized.
  • We take a rigorous approach to every aspect of our work to ensure that what we are building will be useful in building better lives for all people.

Our Staff

Meredith Guerrero
Meredith E. Guerrero, MS
Chief Operating Officer

Ms. Guerrero direct the daily operations of COLS and oversees patient recruitment and retention strategies.

View

Board of Directors

Larry Gold, PhD
Founder and Board Chairman

Dr. Gold, a biomedical researcher, founded multiple biotech companies, including SomaLogic, NeXagen, and Synergen.

View
Phyllis M. Wise, PhD
Chief Executive Officer

Dr. Wise, a biomedical researcher and academic leader, oversees COLS biospecimen program and all research.

View
Don M. Elliman Jr.
Board Member

Mr. Elliman, CU Anschutz Chancellor, is a former publishing executive and active on many Colorado boards.

View
Ginger Graham
Ginger L. Graham, MBA
Board Member

Ms. Graham, former CEO of Amylin, was named one of 40 most influential people in pharmaceuticals.

View
Alan Rudolph, PhD
Board Member

Dr. Rudolph, VP for Research for Colorado State University, is a renowned neuroengineering researcher.

View
Nelson Trujillo, MD
Board Member

Dr. Trujillo is a board-certified cardiologist at Boulder Community Hospital and conducts proteomic research.

View

COLS Advisors

COLS  is a unique resource that is meant to support health research currently not possible. As we create this resource, it is essential to build systems to collect and store biospecimens and personal health data in a manner that will meet the research needs of the next generation. Sample integrity and data universality is critical.

COLS is working with experts around the world on this project. We are extremely grateful for the openness and cooperation from other biobanks as well as the guidance of many experts. A core group of advisors, highlighted here, continues to provide COLS with invaluable assistance. These experts have given generously of their time and talent, and we are eternally grateful.

Kathleen C. Barnes, PhD
Director, Colorado Center for Personalized Medicine, University of Colorado School of Medicine
Dana Dabelea, MD, PhD
Director, Center for Lifecourse Epidemiology of Adoposity and Diabetes; Professor of Epidemiology and Pediatrics, Colorado School of Public Health
Romana Hasnain-Wynia, PhD
Chief Research Officer, Denver Health; Trustee, Colorado Health Institute; Editorial Board Member, Health Affairs
Larry Hunter, PhD
Director, University of Colorado Computational Bioscience Program; Professor of Pharmacology, University of Colorado School of Medicine
Frank Prendergast, MD, PhD
Edmond and Marion Guggenheim Professor Emeritus of Biochemistry and Molecular Biology; Professor Emeritus, Molecular Pharmacology and Experimental Therapeutics, Mayo Medical School
Parminder Raina, PhD
Principal Investigator, Canadian Longitudinal Study on Aging; Scientific Director, McMaster Research Institute for Research on Aging and The Labarge Centre for Mobility in Aging; Professor, McMaster University
John Reilly, MD
Dean, University of Colorado School of Medicine; Vice Chancellor for Health Affairs, University of Colorado Anschutz; Richard D. Krugman Endowed Chair
Elio Riboli, MD
Director, School of Public Health, Imperial College of London; Professor, Cancer Epidemiology and Prevention; Inaugural Principal Investigator, European Prospective Investigation into Cancer and Nutrition
David Rosenman, MD
Hospital-based Physician at Mayo Clinic Alix School of Medicine; Visiting Scholar, Massachusetts Institute of Technology Sloan School of Management
English